ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

August 9, 1985

In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate

September 1, 1978

Regular Exercise May Prevent Cancer, Improve Survival

April 30, 2004

No Justification Provided: AAUP Demands Reinstatement of Faculty Denied Tenure Renewal at MD Anderson

May 16, 2014

DCCR Plans Three Multiple Contracts In Pain Control

February 17, 1978

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000